AstraZeneca To Buy Alexion For $39 Billion To Expand In Immunology

Britain's AstraZeneca has agreed to buy U.S. drugmaker Alexion Pharmaceuticals for $39 billion in cash and shares to bolster its positions in immunology and rare diseases.

from Top Business News- News18.com